Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:7828136rdf:typepubmed:Citationlld:pubmed
pubmed-article:7828136lifeskim:mentionsumls-concept:C0027651lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C0035647lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C0031809lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C0206659lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C1336708lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C0027627lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C0449468lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C0441778lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C1441616lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C0205251lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C0205210lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C1518411lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C0205262lld:lifeskim
pubmed-article:7828136lifeskim:mentionsumls-concept:C1514485lld:lifeskim
pubmed-article:7828136pubmed:issue3lld:pubmed
pubmed-article:7828136pubmed:dateCreated1995-2-17lld:pubmed
pubmed-article:7828136pubmed:abstractTextThirty percent of patients with clinical Stage A nonseminomatous testicular germ cell tumor (NSGCT) are incorrectly clinically staged. In a previous retrospective study at Indiana University, the combination of tumor proliferation rates by flow cytometry and histopathologic evaluation defined risk groups for occult metastatic disease in these patients with clinical Stage A NSGCT: A new immunohistochemical proliferation marker (MIB-1) was therefore used to assess growth fraction in combination with histopathology in an effort to predict pathologic stage in patients with clinical Stage A NSGCT:lld:pubmed
pubmed-article:7828136pubmed:languageenglld:pubmed
pubmed-article:7828136pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7828136pubmed:citationSubsetAIMlld:pubmed
pubmed-article:7828136pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7828136pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7828136pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7828136pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7828136pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:7828136pubmed:statusMEDLINElld:pubmed
pubmed-article:7828136pubmed:monthFeblld:pubmed
pubmed-article:7828136pubmed:issn0008-543Xlld:pubmed
pubmed-article:7828136pubmed:authorpubmed-author:DonohueJ PJPlld:pubmed
pubmed-article:7828136pubmed:authorpubmed-author:AlbersPPlld:pubmed
pubmed-article:7828136pubmed:authorpubmed-author:MillerG AGAlld:pubmed
pubmed-article:7828136pubmed:authorpubmed-author:AlbertUUlld:pubmed
pubmed-article:7828136pubmed:authorpubmed-author:FosterR SRSlld:pubmed
pubmed-article:7828136pubmed:authorpubmed-author:OraziAAlld:pubmed
pubmed-article:7828136pubmed:authorpubmed-author:UlbrightT MTMlld:pubmed
pubmed-article:7828136pubmed:issnTypePrintlld:pubmed
pubmed-article:7828136pubmed:day1lld:pubmed
pubmed-article:7828136pubmed:volume75lld:pubmed
pubmed-article:7828136pubmed:ownerNLMlld:pubmed
pubmed-article:7828136pubmed:authorsCompleteYlld:pubmed
pubmed-article:7828136pubmed:pagination844-50lld:pubmed
pubmed-article:7828136pubmed:dateRevised2010-3-24lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:meshHeadingpubmed-meshheading:7828136-...lld:pubmed
pubmed-article:7828136pubmed:year1995lld:pubmed
pubmed-article:7828136pubmed:articleTitleImmunohistochemical assessment of tumor proliferation and volume of embryonal carcinoma identify patients with clinical stage A nonseminomatous testicular germ cell tumor at low risk for occult metastasis.lld:pubmed
pubmed-article:7828136pubmed:affiliationDepartment of Urology and Pathology, Indiana University Medical Center, Indianapolis.lld:pubmed
pubmed-article:7828136pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:7828136pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:7828136lld:pubmed